158 related articles for article (PubMed ID: 36897757)
1. Overexpression of ASPH protein predicts poor outcomes in retroperitoneal liposarcoma patients.
Xiao M; Chen X; Chen W; Wang L; Rao X; Luo C
Chin Med J (Engl); 2023 Sep; 136(17):2113-2115. PubMed ID: 36897757
[No Abstract] [Full Text] [Related]
2. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
3. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update.
Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X
Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586
[TBL] [Abstract][Full Text] [Related]
5. CircTM7SF3 contributes to oxidized low-density lipoprotein-induced apoptosis, inflammation and oxidative stress through targeting miR-206/ASPH axis in atherosclerosis cell model in vitro.
Wang X; Bai M
BMC Cardiovasc Disord; 2021 Feb; 21(1):51. PubMed ID: 33526034
[TBL] [Abstract][Full Text] [Related]
6. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
[TBL] [Abstract][Full Text] [Related]
7. [The distribution and expression pro-files of Aspartyl/Asparaginyl beta-hydroxylase (ASPH) in some tumorous cell lines and tissues].
Song K; Xue XP; Wang W; Huyan T; Wang H; Yang H; Xie Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):141-4. PubMed ID: 20230674
[TBL] [Abstract][Full Text] [Related]
8. Aspartate β-hydroxylase as a target for cancer therapy.
Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R
J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.
Zou Q; Hou Y; Wang H; Wang K; Xing X; Xia Y; Wan X; Li J; Jiao B; Liu J; Huang A; Wu D; Xiang H; Pawlik TM; Wang H; Lau WY; Wang Y; Shen F
EBioMedicine; 2018 May; 31():287-298. PubMed ID: 29764768
[TBL] [Abstract][Full Text] [Related]
10. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N
Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968
[TBL] [Abstract][Full Text] [Related]
11. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J
J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing identified a novel homozygous ASPH frameshift variant causing Traboulsi syndrome in a Chinese family.
Lei C; Guo T; Ding S; Liao L; Peng H; Tan Z; Luo H
Mol Genet Genomic Med; 2021 Jan; 9(1):e1553. PubMed ID: 33217155
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
Zhang Y; Gao Y; Li Y; Zhang X; Xie H
Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
[TBL] [Abstract][Full Text] [Related]
14. [Expression of
Li C; Li HJ; Chen Q; Zhang XM; Li CL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):54-58. PubMed ID: 29737090
[TBL] [Abstract][Full Text] [Related]
15. Loss of ciliary zonule protein hydroxylation and lens stability as a predicted consequence of biallelic ASPH variation.
Siggs OM; Souzeau E; Craig JE
Ophthalmic Genet; 2019 Feb; 40(1):12-16. PubMed ID: 30600741
[TBL] [Abstract][Full Text] [Related]
16. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR
Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964
[TBL] [Abstract][Full Text] [Related]
17. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
[TBL] [Abstract][Full Text] [Related]
18. Mutations in ASPH cause facial dysmorphism, lens dislocation, anterior-segment abnormalities, and spontaneous filtering blebs, or Traboulsi syndrome.
Patel N; Khan AO; Mansour A; Mohamed JY; Al-Assiri A; Haddad R; Jia X; Xiong Y; Mégarbané A; Traboulsi EI; Alkuraya FS
Am J Hum Genet; 2014 May; 94(5):755-9. PubMed ID: 24768550
[TBL] [Abstract][Full Text] [Related]
19. Circ_ASPH promotes cholangiocarcinoma growth and metastasis through the miR-581/ATP-binding cassette transporter G1 signaling pathway.
Xu Y; Kang P; Leng K; Yao Y; Liao G; Han Y; Shi G; Zhong X; Cui Y
Cancer Commun (Lond); 2020 Oct; 40(10):545-550. PubMed ID: 32735059
[No Abstract] [Full Text] [Related]
20. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review).
Zheng W; Wang X; Hu J; Bai B; Zhu H
Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
